Table 2 Features associated with the detection of atrial fibrillation
From: Atrial fibrillation in cancer survivors – a systematic review and meta-analysis
Variable | Number of studies | β (95% C.I) | P value |
|---|---|---|---|
Age (years) | 16 | 0.00 (-0.002– 0.002) | 0.92 |
Hypertension (%) | 13 | -0.0001 (-0.0008–0.0006) | 0.71 |
Diabetes Mellitus (%) | 12 | -0.0002 (-0.002–0.001) | 0.81 |
Ischaemic Heart Disease (%) | 7 | -0.001 (-0.02–0.02) | 0.88 |
Heart Failure (%) | 7 | -0.005 (-0.03–0.02) | 0.66 |
Previous stroke (%) | 3 | -0.000001 (-0.00005–0.00005) | 0.83 |
Male gender | 14 | 0.00 (-0.00009–0.0002) | 0.35 |
Study design | 16 | 0.01 (-0.02–0.05) | 0.43 |
Cancer type | 16 | 0.0006 (-0.008–0.01) | 0.89 |
Treatment type | 11 | 0.04 (-0.15–0.24) | 0.62 |